A novel cell-free therapy restored hair growth, improved follicle structure, and showed no toxicity in preclinical models. Read more.
For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
In patients with autoimmune hemolytic anemia (AIHA), the risk of relapse is high owing to persistent autoreactive B-cell activity. Multirefractory AIHA is a more advanced stage of disease that is ...
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...
Labroots is pleased to announce the 2nd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Therapy planning committee will invite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results